Herbal medicine for hot flushes induced by endocrine therapy in women with breast cancer: A systematic review and meta-analysis

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Li, Yuanqing ^a   Zhu, Xiaoshu ^b   Bensussan, Alan ^b   Li, Pingping ^a   Moylan, Eugene ^c   Delaney, Geoff ^c   McPherson, Luke ^b  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b WESTERN SYDNEY UNIVERSITY   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ALTERNATIVE MEDICINE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; CLINICAL EFFECTIVENESS; FEMALE; HERBAL MEDICINE; HOT FLUSH; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

EID: 84978706278     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/1327251     Document Type: Review

References (53)

1. Y. Zhang and Y. Liu, "Endocrine therapy for breast cancer: past and present, " Zhonghua Yi Shi Za Zhi, vol. 45, no. 1, pp. 28-32, 2015.
2. J. S. Carpenter, D. Johnson, L. Wagner, and M. Andrykowski, "Hot flashes and related outcomes in breast cancer survivors and matched comparison women, " Oncology Nursing Forum, vol. 29, no. 3, pp. E16-E25, 2002.
3. M. S. Hunter, E. A. Grunfeld, S. Mittal, et al., "Menopausal symptoms in women with breast cancer: prevalence and treatment preferences, " Psycho-Oncology, vol. 13, no. 11, pp. 769-778, 2004.
4. F. Kronenberg, "Hot flashes: phenomenology, quality of life, and search for treatment options, " ExperimentalGerontology, vol. 29, no. 3-4, pp. 319-336, 1994.
5. A. Buzdar, A. Howell, and J. Cuzick, "Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-termsafety analysis of the ATAC trial, " The Lancet Oncology, vol. 7, no. 8, pp. 633-643, 2006.
6. R. Coombes, L. Kilburn, and C. Snowdon, "Survival and safety of exemestane versus tamoxifen after 2-3 yearstamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial, " The Lancet Oncology, vol. 369, pp. 559-570, 2007.
7. P. E. Goss, J. N. Ingle, S. Martino, et al., "Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA. 17, " Journal of the National Cancer Institute, vol. 97, no. 17, pp. 1262-1271, 2005.
8. H. Mouridsen, A. Giobbie-Hurder, A. Goldhirsch, et al., "Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer, " The New England Journal of Medicine, vol. 361, no. 8, pp. 766-776, 2009.
9. M. T. King, P. Kenny, A. Shiell, J. Hall, and J. Boyages, "Quality of life three months and one year after first treatment for early stage breast cancer: influence of treatment and patient characteristics, " Quality of Life Research, vol. 9, no. 7, pp. 789-800, 2000.
10. R. R. Love, L. Cameron, B. L. Connell, and H. Leventhat, "Symptoms associated with tamoxifen treatment in postmenopausal women, " Archives of Internal Medicine, vol. 151, no. 9, pp. 1842-1847, 1991.
11. B. S. Reichman and K. B. Green, "Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects, " Journal of the National Cancer Institute, vol. 16, pp. 125-129, 1994.
12. R. R. Freedman and C. M. Blacker, "Estrogen raises the sweating threshold in postmenopausal womenwith hot flashes, " Fertility and Sterility, vol. 77, no. 3, pp. 487-490, 2002.
13. S. A. Shumaker, C. Legault, S. R. Rapp, et al., "Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women-The Womens Health InitiativeMemory study: a randomized controlled trial, " Journal of the American Medical Association, vol. 289, no. 20, pp. 2651-2662, 2003.
14. J. Eden, "Progestins and breast cancer, " American Journal of Obstetrics & Gynecology, vol. 188, no. 5, pp. 1123-1131, 2003.
15. P. Sismondi, R. Kimmig, E. Kubista, et al., "Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients-data from LIBERATE trial, " Maturitas, vol. 70, no. 4, pp. 365-372, 2011.
16. C. L. Loprinzi, J. W. Kugler, J. A. Sloan, et al., "Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial, " The Lancet, vol. 356, no. 9247, pp. 2059-2063, 2000.
17. S. M. David, S. Salzillo, P. Bowe, et al., "Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast cancer survivors: a pilot study, " BMJ Open, vol. 3, no. 9, Article ID e003138, 2013.
18. L. Bordeleau, K. I. Pritchard, C. L. Loprinzi, et al., "Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors, " Journal of Clinical Oncology, vol. 28, no. 35, pp. 5147-5152, 2010.
19. C. L. Loprinzi, J. A. Sloan, E. A. Perez, et al., "Phase III evaluation of fluoxetine for treatment of hot flashes, " Journal of Clinical Oncology, vol. 20, no. 6, pp. 1578-1583, 2002.
20. K. J. Pandya, R. F. Raubertas, P. J. Flynn, et al., "Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study, " Annals of Internal Medicine, vol. 132, no. 10, pp. 788-793, 2000.
21. C. Buijs, C. H. Mom, P. H. B. Willemse, et al., "Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study, " Breast Cancer Research and Treatment, vol. 115, no. 3, pp. 573-580, 2009.
22. E. Struble, Y. Dice, D. L. Ornstein, et al., "Gabapentin versus venlafaxine for the treatment of menopausal symptoms: a preliminary report, " Breast Cancer Research and Treatment, vol. 88, supplement 1, pp. 240-241, 2004, (abstract #6061).
23. L. Weber and H. L. Thacker, "Paroxetine: a first for selective serotonin reuptake inhibitors-a new use: approved for vasomotor symptoms in postmenopausal women, " Womens Health, vol. 10, no. 2, pp. 147-154, 2014.
24. J. E. Desmarais and K. J. Looper, "Interactions between tamoxifen and antidepressants via cytochrome P450 2D6, " Journal of Clinical Psychiatry, vol. 70, no. 12, pp. 1688-1697, 2009.
25. L. Binkhorst, R. H. J. Mathijssen, M. P. P. VanHerk-Sukel, et al., "Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen, " Breast Cancer Research and Treatment, vol. 139, no. 3, pp. 923-929, 2013.
26. D. L. Barton, C. L. Loprinzi, S. K. Quella, et al., "Prospective evaluation of vitamin E for hot flashes in breast cancer survivors, " Journal of Clinical Oncology, vol. 16, no. 2, pp. 495-500, 1998.
27. N. Biglia, P. Sgandurra, E. Peano, et al., "Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E, " Climacteric, vol. 12, no. 4, pp. 310-318, 2009.
28. World Health Organization, General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine, World Health Organization, Geneve, Switzerland, 2008, http://www.who.int/medicines/areas/traditional/definitions/en/.
29. L. Khaodhiar, H. A. Ricciotti, L. Li, et al., "Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women, " Menopause, vol. 15, no. 1, pp. 125-132, 2008.
30. C. L. Van Patten, I. A. Olivotto, G. K. Chambers, et al., "Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial, " Journal of Clinical Oncology, vol. 20, no. 6, pp. 1449-1455, 2002.
31. J. S. Jacobson, A. B. Troxel, J. Evans, et al., "Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer, " Journal of Clinical Oncology, vol. 19, no. 10, pp. 2739-2745, 2001.
32. R. Erkkola, S. Vervarcke, S. Vansteelandt, P. Rompotti, D. De Keukeleire, and A. Heyerick, "A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts, " Phytomedicine, vol. 17, no. 6, pp. 389-396, 2010.
33. M. C. Colli, A. Bracht, A. A. Soares, et al., "Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms, " Journal of Medicinal Food, vol. 15, no. 9, pp. 840-845, 2012.
34. T. Kohama and M. Negami, "Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women, " The Journal of ReproductiveMedicine, vol. 58, pp. 39-46, 2013.
35. M. S. Lee, B.-C. Shin, E. J. Yang, H.-J. Lim, and E. Ernst, "Maca (Lepidium meyenii) for treatment of menopausal symptoms: a systematic review, " Maturitas, vol. 70, no. 3, pp. 227-233, 2011.
36. Y.-R. Liu, Y.-L. Jiang, R.-Q. Huang, J.-Y. Yang, B.-K. Xiao, and J.-X. Dong, "Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety, " Climacteric, vol. 17, no. 4, pp. 325-335, 2014.
37. S. H. Kwee, H. H. Tan, A. Marsman, and C. Wauters, "The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo, " Maturitas, vol. 58, no. 1, pp. 83-90, 2007.
38. H. Fritz, D. Seely, G. Flower, et al., "Soy, red clover, and isoflavones and breast cancer: a systematic review, " PLoS ONE, vol. 8, no. 11, Article ID e81968, 2013.
39. M. J. Leach and V. Moore, "Black cohosh (Cimicifuga spp. ) for menopausal symptoms, " Cochrane Database of Systematic Reviews, no. 9, Article ID CD007244, 2012.
40. H. Roberts, "Safety of herbalmedicinal products inwomenwith breast cancer, " Maturitas, vol. 66, no. 4, pp. 363-369, 2010.
41. F. Borrelli and E. Ernst, "Black cohosh (Cimicifuga racemosa): a systematic review of adverse events, " American Journal of Obstetrics and Gynecology, vol. 199, no. 5, pp. 455-466, 2008.
42. H. Fritz, D. Seely, J. McGowan, and B. Skidmore, "Black cohosh and breast cancer: a systematic review, " Integrative Cancer Therapies, vol. 13, no. 1, pp. 12-29, 2014.
43. G. Hernandez Munoz and S. Pluchino, "Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer, " Maturitas, vol. 44, supplement 1, pp. S59-S65, 2003.
44. Y. L. Jiang, Y. Zhao, and M. Cai, "Clinical research of kidneyreinforcing and liver-regulatingformula in treating breast cancer patientswith perimenopausal syndrome, " Journal of Traditional Chinese Medicine University of Hunan, vol. 32, no. 11, pp. 61-64, 2012.
45. T. Li and R. Zuo, "Clinical study of toxic and side effect of Zhibai DihuangWan decrease the tamoxifen in treating breast cancer, " Guangxi Journal of Traditional Chinese Medicine, vol. 32, no. 4, pp. 6-8, 2009.
46. H. Sun, D. Xue, and F. Gao, "Effect of shugan liangxue compound for relieving hot flashes in breast cancer patients, " Chinese Journal of Integrated Traditional andWesternMedicine, vol. 29, no. 1, pp. 30-33, 2009.
47. P. Y. Zhang, W. P. Lu, and H. H. Ling, "The clinieal study on management of side effects of endocrine therapy (Tamoxifen) on breast cancer patients in post surgery with TCM treating principle of regulating liver Qi and tonifying kidney yin, " Journal of Traditional Chinese Medicine, vol. 31, no. 4, pp. 309-311, 2000.
48. J. P. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Cochrane Book Series, The Cochrane Collaboration, Wiley Online Library, 2008.
49. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, "Measuring inconsistency in meta-analyses, " The British Medical Journal, vol. 327, no. 7414, pp. 557-560, 2003.
50. C. L. Zhang and Y. L. Zhen, "Clinical study of Dan Zhi Xiao Yao San and Er Zhi Wan Jia Jian in treating the hormone therapy of breast cancer the clinical observation of after menopause syndrome, " China Journal of Chinese Medcine, vol. 27, no. 164, pp. 6-8, 2012.
51. P. Amato, S. Christophe, and P. L. Mellon, "Estrogenic activity of herbs commonly used as remedies for menopausal symptoms, " Menopause, vol. 9, no. 2, pp. 145-150, 2002.
52. A. L. Ososki and E. J. Kennelly, "Phytoestrogens: a review of the present state of research, " Phytotherapy Research, vol. 17, no. 8, pp. 845-869, 2003.
53. M. S. Kurzer, "Phytoestrogen supplement use by women, " Journal of Nutrition, vol. 133, no. 6, pp. 1983s-1986s, 2003.